Multi-disciplinary Thoracic Oncology: State-of-the-art and new directions

Overall Goals

This one day CME accredited educational course will focus on significant updates on the state-of-the-art screening, work-up, diagnosis, staging and treatment of thoracic malignancies highlighting the need of multi-disciplinary management of complex diseases, such as small cell and non-small cell lung cancer, thymic malignancies and mesothelioma. Two major sessions will review management aspects of curable stages of non-small cell lung cancer as well as other less common thoracic malignancies. A keynote presentation, given by an internationally recognized thought leader, will review major updates from the 2014 ASCO meeting. One major session will be dedicated to provide updates on major progress made in the management of advanced non-small cell lung cancer through molecular testing, targeted and immunotherapies. Challenging case presentations presented in a Tumor Board format will highlight key management aspects of complex cases and attendee participation and interaction will be facilitated through Q&A and interactive panel discussions.

Learning Objectives

• Define the appropriate implementation of CT screening for lung cancer in high-risk patients and work-up of findings
• Recognize recent advancements in surgical, radiation and chemotherapy treatments for patients with curable non-small cell lung cancer
• Discuss the multi-disciplinary treatment of less common thoracic malignancies, such as thymoma, small cell lung cancer and mesothelioma
• Explain recent progress in the management of advanced non-small cell lung cancer through use of state-of-the-art molecular testing approaches and novel targeted and immunotherapies
• Identify the incorporation of findings into day-to-day practice setting through presentations and discussions of complex and challenging cases

Target Audience

This activity is designed for internists, medical and radiation oncologists, nurses, physician assistants, pulmonologists, radiologists, respiratory therapists, thoracic surgeons, and other medical professionals involved in the screening and evaluation of high-risk patients as well as the diagnosis, staging and/or management of patients with thoracic malignancies.

Program Co-Directors

Balazs Halmos, MD
Jeffrey L. Port, MD
Ronald J. Scheff, MD
Joshua R. Sonett, MD, FACS